The Clarity Diagnostics WELLlife™ COVID-19 and Influenza A & B Rapid Test Kit provides a rapid, qualitative multiplex immunoassay for the simultaneous detection and differentiation of SARS-CoV-2, Influenza A, and Influenza B viral nucleocapsid antigens. Designed to streamline differential diagnosis during respiratory virus season, this point-of-care assay utilizes direct anterior nasal swab specimens to deliver clear, visual results in 15 minutes. By enabling healthcare providers to quickly distinguish between COVID-19 and flu infections from a single patient swab without complex laboratory equipment, the WELLlife™ kit supports prompt clinical decision-making, targeted antiviral therapy, and effective infection control.
